With its `80% gross margins, CTSO can be an elite moneymaker and cash cow. The problem is not sales or more government approvals. It is management's desire to constantly "investment spend for the future." Hopefully, last quarter was the worst we will see with the expansion of the headquarters facilities and related cost. This is like living with a spouse who constantly runs a credit card to the limit, and you have to pay the bill. Keep in mind that medical professionals are running this company, not business professionals. They don't particularly care about EPS or P/Es. They should. Perhaps as they get closer to retirement and want to have more money in the bank, it will dawn on them that the "financial health" of CTSO is as important as the work that the company does. If they take their foot off the gas pedal on "investment spending" and manage the company to show its true profitability, the stock price will soar. Each quarterly report, I hope to see signs that this is happening. The best thing would be to replace the medical professionals with business professionals to manage the company from an investor's point of view. At some point, it will happen. Meanwhile, keep your eye on gross margins and where all that profit is spent. This is the key to stock price for CTSO. When P/E shows profitability, the stock price will soar. I have been invested in CTSO since annual sales were $348k, and now it is roughly $40 million and still climbing. The company can sell high margin products. They just don't know how to hold onto profits. Maybe we'll see improvements in Q2.
